Sun Pharma, Cipla recall medicines in US over manufacturing issues
New Delhi, Jan 26 (IANS) Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).